383 related articles for article (PubMed ID: 21372750)
1. Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population.
Dutta A; Palazzi DL
Pediatr Infect Dis J; 2011 Aug; 30(8):664-8. PubMed ID: 21372750
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
Davis SL; Vazquez JA; McKinnon PS
Ann Pharmacother; 2007 Apr; 41(4):568-73. PubMed ID: 17374623
[TBL] [Abstract][Full Text] [Related]
3. Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections.
Safdar A; Hanna HA; Boktour M; Kontoyiannis DP; Hachem R; Lichtiger B; Freireich EJ; Raad II
Cancer; 2004 Dec; 101(12):2859-65. PubMed ID: 15529309
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of candidemia at a Children's hospital, 2002 to 2006.
Neu N; Malik M; Lunding A; Whittier S; Alba L; Kubin C; Saiman L
Pediatr Infect Dis J; 2009 Sep; 28(9):806-9. PubMed ID: 19636286
[TBL] [Abstract][Full Text] [Related]
5. Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain.
Rodríguez D; Almirante B; Cuenca-Estrella M; Rodríguez-Tudela JL; Mensa J; Ayats J; Sanchez F; Pahissa A;
Clin Microbiol Infect; 2010 Nov; 16(11):1676-82. PubMed ID: 20219079
[TBL] [Abstract][Full Text] [Related]
6. Candidemic complications in patients with intravascular catheters colonized with Candida species: an indication for preemptive antifungal therapy?
Leenders NH; Oosterheert JJ; Ekkelenkamp MB; De Lange DW; Hoepelman AI; Peters EJ
Int J Infect Dis; 2011 Jul; 15(7):e453-8. PubMed ID: 21530350
[TBL] [Abstract][Full Text] [Related]
7. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
Al-Tawfiq JA
Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
[TBL] [Abstract][Full Text] [Related]
8. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
[TBL] [Abstract][Full Text] [Related]
9. [Study on the morbidity and pathogens of patients with candidemia at the intensive care unit].
Yin QQ; Zhang YT; Fang Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):464-8. PubMed ID: 18956679
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt.
Hegazi M; Abdelkader A; Zaki M; El-Deek B
J Infect Dev Ctries; 2014 May; 8(5):624-34. PubMed ID: 24820467
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital].
Yenigün Koçak B; Kuloğlu F; Doğan Çelik A; Akata F
Mikrobiyol Bul; 2011 Jul; 45(3):489-503. PubMed ID: 21935782
[TBL] [Abstract][Full Text] [Related]
12. The predictors of outcome in immunocompetent patients with hematogenous candidiasis.
Safdar A; Bannister TW; Safdar Z
Int J Infect Dis; 2004 May; 8(3):180-6. PubMed ID: 15109594
[TBL] [Abstract][Full Text] [Related]
13. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
[TBL] [Abstract][Full Text] [Related]
14. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of community-onset candidemia in Connecticut and Maryland.
Sofair AN; Lyon GM; Huie-White S; Reiss E; Harrison LH; Sanza LT; Arthington-Skaggs BA; Fridkin SK
Clin Infect Dis; 2006 Jul; 43(1):32-9. PubMed ID: 16758415
[TBL] [Abstract][Full Text] [Related]
16. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
17. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.
Chi HW; Yang YS; Shang ST; Chen KH; Yeh KM; Chang FY; Lin JC
J Microbiol Immunol Infect; 2011 Oct; 44(5):369-75. PubMed ID: 21524971
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
19. Fungemia in non-HIV-infected patients: a five-year review.
Anunnatsiri S; Chetchotisakd P; Mootsikapun P
Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of species distribution and risk factors of candidemia: a multicenter case-control study.
Yapar N; Pullukcu H; Avkan-Oguz V; Sayin-Kutlu S; Ertugrul B; Sacar S; Cetin B; Kaya O
Med Mycol; 2011 Jan; 49(1):26-31. PubMed ID: 20662635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
